These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 16458421)

  • 1. Blockade of the chemokine receptor CXCR2 inhibits pancreatic cancer cell-induced angiogenesis.
    Wente MN; Keane MP; Burdick MD; Friess H; Büchler MW; Ceyhan GO; Reber HA; Strieter RM; Hines OJ
    Cancer Lett; 2006 Sep; 241(2):221-7. PubMed ID: 16458421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Broad-spectrum G protein-coupled receptor antagonist, [D-Arg1,D-Trp5,7,9,Leu11]SP: a dual inhibitor of growth and angiogenesis in pancreatic cancer.
    Guha S; Eibl G; Kisfalvi K; Fan RS; Burdick M; Reber H; Hines OJ; Strieter R; Rozengurt E
    Cancer Res; 2005 Apr; 65(7):2738-45. PubMed ID: 15805273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity.
    Addison CL; Daniel TO; Burdick MD; Liu H; Ehlert JE; Xue YY; Buechi L; Walz A; Richmond A; Strieter RM
    J Immunol; 2000 Nov; 165(9):5269-77. PubMed ID: 11046061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A growth-related oncogene/CXC chemokine receptor 2 autocrine loop contributes to cellular proliferation in esophageal cancer.
    Wang B; Hendricks DT; Wamunyokoli F; Parker MI
    Cancer Res; 2006 Mar; 66(6):3071-7. PubMed ID: 16540656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of angiogenesis by the C-X-C chemokines interleukin-8 and epithelial neutrophil activating peptide 78 in the rheumatoid joint.
    Koch AE; Volin MV; Woods JM; Kunkel SL; Connors MA; Harlow LA; Woodruff DC; Burdick MD; Strieter RM
    Arthritis Rheum; 2001 Jan; 44(1):31-40. PubMed ID: 11212173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High expression of ligands for chemokine receptor CXCR2 in alveolar epithelial neoplasia induced by oncogenic kras.
    Wislez M; Fujimoto N; Izzo JG; Hanna AE; Cody DD; Langley RR; Tang H; Burdick MD; Sato M; Minna JD; Mao L; Wistuba I; Strieter RM; Kurie JM
    Cancer Res; 2006 Apr; 66(8):4198-207. PubMed ID: 16618742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXC chemokines located in the 4q21 region are up-regulated in breast cancer.
    Bièche I; Chavey C; Andrieu C; Busson M; Vacher S; Le Corre L; Guinebretière JM; Burlinchon S; Lidereau R; Lazennec G
    Endocr Relat Cancer; 2007 Dec; 14(4):1039-52. PubMed ID: 18045955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXC-chemokine/CXCR2 biological axis promotes angiogenesis in vitro and in vivo in pancreatic cancer.
    Matsuo Y; Raimondo M; Woodward TA; Wallace MB; Gill KR; Tong Z; Burdick MD; Yang Z; Strieter RM; Hoffman RM; Guha S
    Int J Cancer; 2009 Sep; 125(5):1027-37. PubMed ID: 19431209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate tumor CXC-chemokine profile correlates with cell adhesion to endothelium and extracellular matrix.
    Engl T; Relja B; Blumenberg C; Müller I; Ringel EM; Beecken WD; Jonas D; Blaheta RA
    Life Sci; 2006 Mar; 78(16):1784-93. PubMed ID: 16263140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bronchial smooth muscle cells of asthmatics promote angiogenesis through elevated secretion of CXC-chemokines (ENA-78, GRO-α, and IL-8).
    Keglowich L; Roth M; Philippova M; Resink T; Tjin G; Oliver B; Lardinois D; Dessus-Babus S; Gosens R; Hostettler Haack K; Tamm M; Borger P
    PLoS One; 2013; 8(12):e81494. PubMed ID: 24339939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of sites subjected to serine/threonine phosphorylation by SGK1 affecting N-myc downstream-regulated gene 1 (NDRG1)/Cap43-dependent suppression of angiogenic CXC chemokine expression in human pancreatic cancer cells.
    Murakami Y; Hosoi F; Izumi H; Maruyama Y; Ureshino H; Watari K; Kohno K; Kuwano M; Ono M
    Biochem Biophys Res Commun; 2010 May; 396(2):376-81. PubMed ID: 20416281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ELR+ CXC chemokines and their receptors (CXC chemokine receptor 1 and CXC chemokine receptor 2) as new therapeutic targets.
    Bizzarri C; Beccari AR; Bertini R; Cavicchia MR; Giorgini S; Allegretti M
    Pharmacol Ther; 2006 Oct; 112(1):139-49. PubMed ID: 16720046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth-regulated oncogene is pivotal in thrombin-induced angiogenesis.
    Caunt M; Hu L; Tang T; Brooks PC; Ibrahim S; Karpatkin S
    Cancer Res; 2006 Apr; 66(8):4125-32. PubMed ID: 16618733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXC chemokines: angiogenesis, immunoangiostasis, and metastases in lung cancer.
    Strieter RM; Belperio JA; Burdick MD; Sharma S; Dubinett SM; Keane MP
    Ann N Y Acad Sci; 2004 Dec; 1028():351-60. PubMed ID: 15650260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PPAR-gamma activation inhibits angiogenesis by blocking ELR+CXC chemokine production in non-small cell lung cancer.
    Keshamouni VG; Arenberg DA; Reddy RC; Newstead MJ; Anthwal S; Standiford TJ
    Neoplasia; 2005 Mar; 7(3):294-301. PubMed ID: 15799829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential involvement of IL-8 and its receptors in the invasiveness of pancreatic cancer cells.
    Kuwada Y; Sasaki T; Morinaka K; Kitadai Y; Mukaida N; Chayama K
    Int J Oncol; 2003 Apr; 22(4):765-71. PubMed ID: 12632066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein array technology to detect HER2 (erbB-2)-induced 'cytokine signature' in breast cancer.
    Vazquez-Martin A; Colomer R; Menendez JA
    Eur J Cancer; 2007 May; 43(7):1117-24. PubMed ID: 17379503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of CXC chemokines and their receptors: implications for proinflammatory microenvironments of ovarian carcinomas and endometriosis.
    Furuya M; Suyama T; Usui H; Kasuya Y; Nishiyama M; Tanaka N; Ishiwata I; Nagai Y; Shozu M; Kimura S
    Hum Pathol; 2007 Nov; 38(11):1676-87. PubMed ID: 17707463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRAK/CXCL14 is a potent inhibitor of angiogenesis and a chemotactic factor for immature dendritic cells.
    Shellenberger TD; Wang M; Gujrati M; Jayakumar A; Strieter RM; Burdick MD; Ioannides CG; Efferson CL; El-Naggar AK; Roberts D; Clayman GL; Frederick MJ
    Cancer Res; 2004 Nov; 64(22):8262-70. PubMed ID: 15548693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of CXC chemokines and their receptors in cancer.
    Vandercappellen J; Van Damme J; Struyf S
    Cancer Lett; 2008 Aug; 267(2):226-44. PubMed ID: 18579287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.